<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Multidrug Resistance in Cancer &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/multidrug-resistance-in-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 10:04:37 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Multidrug Resistance in Cancer &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Cracking the Code of Cancer Drug Resistance</title>
		<link>https://bioengineer.org/cracking-the-code-of-cancer-drug-resistance/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 29 Jul 2025 18:58:45 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer Treatment Strategies]]></category>
		<category><![CDATA[Drug resistance mechanisms]]></category>
		<category><![CDATA[Immunotherapy resistance]]></category>
		<category><![CDATA[Multidrug Resistance in Cancer]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cracking-the-code-of-cancer-drug-resistance/</guid>

					<description><![CDATA[Cancer’s relentless capacity to outmaneuver treatment remains one of the most formidable obstacles in modern medicine. Among the most vexing manifestations of this challenge is multidrug resistance (MDR)—a phenomenon wherein tumors evolve the ability to withstand multiple anticancer agents that differ widely in their chemical compositions and therapeutic mechanisms. This sinister adaptability threatens to undermine [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">251792</post-id>	</item>
	</channel>
</rss>
